The ROR gamma Plasmid is a mammalian expression vector construct, pCMV/hRORgamma, containing coding sequence of human RAR-related orphan receptor gamma (GenBank Accession: NM_005060).
This human ROR gamma Plasmid is useful for: Expression of hROR gamma protein in mammalian cells. Induction of IL-17A promoter activity. Total content of 10 ug is enough for one 96-well cell transfection (0.1 ug plasmid per well). Recommended amount for other plate formats: 6-well plate (2 ug/well), 12-well plate (0.8 ug/well) and 24-well plate (0.4 ug/well).
There are no reviews for ROR gamma Plasmid (NBP2-25278).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for ROR gamma Plasmid (NBP2-25278). (Showing 1 - 1 of 1 FAQ).
What is the plasmid sequence for the ROR gamma Plasmid, NBP2-25278?
The ROR gamma Plasmid is a mammalian expression vector construct, pCMV/hRORgamma, containing coding sequence of human RAR-related orphan receptor gamma (GenBank Accession: NM_005060). Please refer to the GenBank Accession No for the coding sequence. The following is the set of primers to check the presence of the full gene insert for NBP2-25278. T7 (Forward): 5’-TAATACGACTCACTATAGGG-3’ BGH (Reverse): 5’-TAGAAGGCACAGTCGAGGC-3’
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.